Triple-negative breast cancer (TNBC) is a subset of breast cancer that does not express the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) [1], and accounts for approximately 20% of breast cancers [2]. Here, ESR1 is linked to breast carcinoma.